Boston Scientific (BSX) Long-Term Debt Issuances (2009 - 2025)

Boston Scientific has disclosed Long-Term Debt Issuances across 15 years of filings, most recently posting $1.6 billion for Q1 2025.

• In Q1 2025, Long-Term Debt Issuances fell 27.37% year-over-year to $1.6 billion; the TTM figure through Dec 2025 stood at $1.6 billion (down 27.37% YoY), while the FY2025 annual figure was $1.6 billion, down 27.37% from the prior year.
• Long-Term Debt Issuances came in at $1.6 billion for Q1 2025 at Boston Scientific, down from $2.1 billion in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $3.3 billion in Q1 2022 to a low of -$1.0 million in Q2 2022.
• Average Long-Term Debt Issuances over 3 years is $1.7 billion, with a median of $1.9 billion recorded in 2024.
• The largest YoY upside for Long-Term Debt Issuances was 27.37% in 2025 against a maximum downside of 27.37% in 2025.
• Over 3 years, Long-Term Debt Issuances stood at -$1.0 million in 2022, then soared by 214600.0% to $2.1 billion in 2024, then slipped by 27.37% to $1.6 billion in 2025.
• Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $1.6 billion in Q1 2025, $2.1 billion in Q1 2024, and -$1.0 million in Q2 2022.